Recursion Pharmaceuticals (RXRX) closed the latest trading day at $5.41, indicating a -1.64% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...

But these same areas are now overcrowded, and price wars are common. Companies like Mankind, Sun Pharma, and Intas are looking at combinations of brand innovation, portfolio reshuffling ...

Of the 12,000 new positions, nearly 6,500 will be in construction and 1,000 at new and expanded facilities, the Swiss pharma giant said. Once capacity comes online at the various facilities ...

And what, pray tell, are you dipping it in? Over the last fifty years, Ireland has become an unlikely global capital for the pharmaceutical industry, thanks to generous tax policies and a ...

Mayne Pharma, which is the target of a $672m foreign takeover bid, appears unperturbed by the likely impact of Donald Trump’s import tariffs on the drug sector. ASX-listed Mayne said it expected ...

When should six drugs count as one? That question is at the heart of an unusual challenge that the pharma company Novo Nordisk is pursuing against the federal government. And the answer could have ...

Exports of Drugs and Pharmaceuticals from the country has registered a 9.39 per cent growth during the financial year 2024-25, with a marginal decline compared to the growth reported in 2023-24 ...

Jamjoom Pharma profit up 22% to SAR 356.5M in 2024; Q4 at SAR 51.6M 12 M 2024 Jamjoom Pharma 9M 2024 profit up 23% to 304.9M; Q3 at SAR 95M 9 M 2024 Jamjoom Pharma H1 2024 net profit rises to SAR ...

In a significant achievement, India’s annual drug and pharmaceutical exports touched an unprecedented record $30 billion in Fiscal Year 2025 bolstered by a 31 percent year-on-year surge in March.

About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families.

Industry Veterans Bring Deep Strategic Experience to Guide Alzheimer’s Clinical Expansion and Commercial Strategy POTOMAC, MARYLAND / ACCESS Newswire / April 21, 2025 / IGC Pharma, Inc. (NYSE ...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...